Complete Abstract PDF

Wednesday, 6 June 2018
7:30 am - 11:30 am Neuwave Hands-On Breakfast Symposium
1:00 pm - 6:00 pm IO Essentials, Part I
1:00 pm - 1:30 pm Introduction Moderator: Sarah White, MD, MS
1:00 pm - 1:15 pm History of IO: How We Got Here
Stephen Solomon, MD
1:15 pm - 1:30 pm Why We Do What We Do
Mary Beth Myers
1:30 pm - 2:45 pm ABCs of a Tumor Board Moderator: Ryan Hickey, MD
1:30 pm - 1:40 pm HCC
Karen Brown, MD
1:40 pm - 1:50 pm mCRC
Resmi Charalel, MD
1:50 pm - 2:00 pm Other Liver Mets
Raj Shah, MD
2:00 pm - 2:10 pm Pancreaticobiliary
Evan Lehrman, MD
2:10 pm - 2:20 pm Renal
Debra Gervais, MD
2:20 pm - 2:30 pm Bone
Matthew Callstrom, MD, PhD
2:30 pm - 2:40 pm Lung
Stephen Solomon, MD
2:45 pm - 3:00 pm Break
3:00 pm - 4:00 pm Tumor Board Moderators: Michael C. Soulen, MD and Anne Covey, MD
4:00 pm - 4:10 pm Break
4:10 pm - 4:55 pm Journal Club Moderators: Nadine Abi-Jaoudeh, MD and Julius Chapiro, MD, PhD
4:10 pm - 4:25 pm How to Critically Review an Article
Alda Tam, MD
4:25 pm - 4:40 pm Pivotal Trials in IO
Riad Salem, MD
4:40 pm - 4:55 pm "Bad" Trials and How to Refute Them
Sharon Kwan, MD
5:00 pm - 6:00 pm Innovation in IO Moderators: Clifford Raabe Weiss, MD and Isabel Newton, MD
5:00 pm - 5:12 pm Device Development
Fred Lee, MD
5:12 pm - 5:24 pm How to Turn a Clinical Question into a Research Project
Joseph Erinjeri, MD
5:24 pm - 5:36 pm Bench to Bedside
Clifford Raabe Weiss, MD
5:36 pm - 5:48 pm Mentor-Mentee Relationship
Michael C. Soulen, MD
5:48 pm - 6:00 pm Leadership: Building a Successful Team
Katharine Krol, MD
6:00 pm - 7:00 pm IO Essentials Reception
7:00 pm - 9:30 pm BTG Dinner Symposium


Thursday, 7 June 2018
7:15 am - 8:15 am BTG Hands-On Breakfast Symposium
8:15 am - 8:30 am Breakfast
8:30 am - 8:45 am Welcome - David C. Madoff, MD
8:45 am - 9:15 am Interventional Oncology as the 4th Pillar: Are We There Yet?
Moderator: David C. Madoff, MD
Speaker: Stephen Solomon, MD
9:30 am - 10:30 am Obtaining Tissue in the Age of Precision Medicine Moderators: Sanjay Gupta, MD and David C. Madoff
9:30 am - 9:40 am IO in the Age of Precision Medicine: How Precise Is It?
Roy Herbst, MD
9:40 am - 9:50 am Role of Image-Guided Biopsy in Oncology Clinical Trials
Alda Tam, MD
9:50 am - 10:00 am Navigational Tools, Needle Designs, and Robotics to Improve Lesion Targeting
Nadine Abi-Jaoudeh, MD
10:00 am - 10:10 am Improving Diagnostic Yield: Molecular Imaging, Radiogenomics, and Optical Imaging
Stephen Solomon, MD
10:10 am - 10:20 am Genomic Analysis: What the IO Needs to Know
Lipika Goyal, MD
10:20 am - 10:30 am Liquid Biopsy: Will Percutaneous Approaches Become Obsolete?
Ryan Corcoran, MD, PhD
10:30 am - 11:15 am Break & Exhibits
11:15 am - 12:15 pm New Frontiers in Ablation Therapy
Industry Symposium Presented by Medtronic
12:15 pm - 12:45 pm Getting to TACE 2.0: Advances from the Pre-Clinical and Clinical World
Education Session Supported by an Unrestricted Grant from Guerbet
12:45 pm - 1:30 pm Break & Exhibits
1:45 pm - 2:30 pm HCC: Current Status Moderators: Riad Salem, MD and Uei Pua, MD
2:30 pm - 2:45 pm Break & Exhibits
2:45 pm - 3:45 pm HCC: Current Status Moderators: Riad Salem, MD and Uei Pua, MD
2:45 pm - 3:00 pm Top 10 Most Important Surgical/Interventional Studies
Riad Salem, MD
3:00 pm - 3:15 pm Contemporary Update on Systemic Treatments: Novel Agents and Immunotherapy
Andrew Zhu, MD
3:15 pm - 3:30 pm SARAH/SIRVENIB: Positive or Negative Trials?
Steve Rose, MD
3:30 pm - 3:45 pm Panel Q&A
All Speakers
3:45 pm - 4:15 pm Break & Exhibits
4:15 pm - 5:15 pm Second Opinions
Moderator: Ravi Murthy, MD
Speakers: Uei Pua, MD; Eduardo Eyheremendy, MD; Kuang Ming, MD; James Caridi, MD; Stephen Solomon, MD; Rony Avritscher, MD; Franco Orsi, MD; and Sarah White, MD, MS
  Renal Ablation: Managing the T1 Renal Mass 
Moderators: Thomas Atwell, MD and Steven Raman, MD
4:15 pm - 4:30 pm When Surgery Trumps Ablation
Adam Feldman, MD
4:30 pm - 4:50 pm Ablation Cornucopia: Choosing A Device
Grant Schmit, MD
4:50 pm - 5:00 pm Adjunctive Techniques During Renal Ablation
David Breen, MD
5:00 pm - 5:10 pm Multidisciplinary Management of the Patient with Metastatic RCC
Rupal Bhatt, MD
5:10 pm - 5:15 pm Q&A
All Faculty
5:15 pm - 5:30 pm Break and Exhibits
5:30 pm - 6:30 pm Most Influential Publications Moderators: David C. Madoff, MD and S. Nahum Goldberg, MD
5:30 pm - 5:35 pm Introduction
David C. Madoff, MD
5:35 pm - 5:46 pm Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
Jonathan Strosberg, MD
5:46 pm - 5:57 pm Targeting sTaT3 to Suppress Systemic Pro-Oncogenic Effects from Hepatic Radiofrequency Ablation
Muneeb Ahmed, MD
5:57 pm - 6:08 pm Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically managed Patients: Analysis of the National Cancer Database
Anil "Nick" Kurup, MD
6:08 pm - 6:19 pm Efficacy and Safety of Selective Internal Radiotherapy with Yttrium-90 Resin Microspheres Compared with Sorafenib in Locally Advanced and Inoperable Heppatocellular Carcinoma (SARAH): An Open-Label Randomized Controlled Phase 3 Trial
Annie Sibert, MD
6:20 pm - 6:30 pm 2018 Best Abstract: Inhibition of PI3K/mTOR/AKT Signaling in Combination with Thermal Ablation Decreases Tumor Growth in a Mouse Model of Hepatocellular Carcinoma
Danielle Jondal
6:30 pm - 7:30 pm Opening Night Reception: SIO Summer Soiree
7:30 pm - 10:00 pm

IO Essentials Game Night 
Steven Solomon, MD; William Rilling, MD; and Michael Soulen, MD

7:30 pm Dinner and Introduction
7:40 pm - 7:55 pm Who Can Ablate a Liver Tumor with Best Margins?
Constantinos Sofocleous MD, PhD vs. Luigi Solbiati, MD
7:55 pm - 8:10 pm Who Can Ablate a Spine Lesion Faster?
Jack Jennings, MD vs. Alexis Kelekis, MD
8:10 pm - 8:30 pm Who Can Embolize Hepatic Vessels with DEBs Faster?
Thor Johnson, MD vs. Evan Lehrman, MD
8:30 pm - 8:50 pm Who Can Perform TACE on a Simulator?
William Rilling, MD vs. Edward Kim, MD
8:50 pm - 9:10 pm Who Can Embolize a GDA Faster?
Bulent Arslan, MD vs. Katharine Krol, MD
9:10 pm - 9:20 pm Who Can Emulsify Lipiodol Faster?
Frederic Deschamps vs. Michael Soulen, MD
9:20 pm - 9:30 pm Who Can Assemble a Therasphere Kit Faster?
Riad Salem, MD vs. Steve Rose, MD
9:30 pm - 9:50 pm Who Can Nano-Knife a Lesion Faster?
Matthew Callstrom, MD, PhD vs. Martijn Meijerink, MD, PhD


Friday, 8 June 2018
7:15 am - 8:15 am Surefire Hands-On Breakfast Symposium
7:30 am - 8:45 am Machine Learning in Interventional Oncology Moderators: Julius Chapiro, MD, PhD and David C. Madoff, MD
7:30 am - 7:45 am Nuts and Bolts of Machine Learning in Interventional Oncology
Aaron Abajian, MD, MS
7:45 am - 8:00 am Big Data and Clinical Outcomes Registries: AI-Based Concepts to Improve Clinical Decision Making in IO
Mark Michalski, MD
8:00 am - 8:15 am The Role of AI in Intraprocedural Imaging and Image Guidance
Raul Uppot, MD
8:15 am - 8:25 am Infrastructure for Machine Learning Research
Brian Letzen, MD, MS
8:25 am - 8:45 am Panel Discussion
Aaron Abajian, MD, MS; Mark Michalski, MD; Raul Uppot, MD; Brian Letzen, MD, MS; and Lynn Savic, MD
7:30 am - 8:45 am Scientific Abstract Presentations: Liver IO Moderators: Ping Liang, MD and Suvranu Ganguli, MD
7:30 am - 7:39 am Paper 2: Safety and Feasibility of Integrating Yttrium-90 Radioembolization with Capecitabine-Temozolomide for Grade 2 Liver-Dominant Metastatic Neuroendocrine Tumors (CapTemY90): Final Report
7:39 am - 7:48 am Paper 3: Study of Mobilizable 125I See Chain Coaxial Drainage Catheter Placement for INtraluminal Brachytherapy of Malignant Obstructive Jaundice
7:48 am - 7:57 am Paper 4: Inflammation Marker as a Biomarker for Overall Survival After Transarterial Chemoemboliztaion: IMportance of Neutrophil-to-Lymphocyte Ratio in Hepatocellular Carcinoma
7:57 am - 8:06 am Paper 5: Multicentric Assessment of the Hong Kong Liver Cancer Staging System in Chinese Patients Following Transarterial Chemoembolization as Initial Treatment
8:06 am - 8:15 am Paper 6: Early Safety From a Phase 1 Multicenter Open-Label Clinical Trial of Talimogene Laherparepvec INjected Into Liver Tumors
8:15 am - 8:24 am Paper 7: Outcomes After Transarterial Embolization Versus Radioembolization of Neuroendocrine Tumor Liver Metastases
8:24 am - 8:33 am Paper 8: Chonic Hepatic Changes in Patients with Metastatic Neuroendocrine Tumors Treated with Y90 Radioembolization: A Single-Center Experience
8:33 am - 8:42 am Paper 9: The effect of TACE/Ablation to the Change of TAA Specific T-Cell Response in Hepatocellular Carcinoma
8:45 am - 9:00 am Break & Exhibits
9:00 am - 10:30 am Latest Advances in Lung Tumor Therapy Moderator: Stephen Solomon, MD and Jean Palussière, MD
9:00 am - 9:12 am Lung Ablation: Lessons from the Lab
Christopher Brace, MD
9:12 am - 9:24 am Evidence for Treating Oligometastatic Lung Metastases
Michael Lanuti, MD
9:24 am - 9:36 am Ablative Therapy for Lung Metastases
Matthew Callstrom, MD, PhD
9:36 am - 9:48 am Ablative Therapy for Primary Lung Cancer
Jean Palussière, MD
9:48 am - 10:00 am Proton Therapy vs. SBRT in Lung Cancer
Henning Willers, MD
10:00 am - 10:12 am Targeted Therapy and Immunotherapy for Lung Cancer
Christopher G. Azzoli, MD
10:12 am - 10:24 am Imaging After Therapy: Ablation, Radiation, and Systemic Therapies
Robert Suh, MD
  Hands-On Workshop: Ablation
Moderator: Fred Lee, MD
Panelists: Hyunchul Rhim, MD; Luigi Solbiati, MD; Grant Schmit, MD; Pei Hong Wu, MD
10:30 am - 11:15 am Break & Exhibits
11:15 am - 12:15 pm Immuno-Oncology: What's on the Horizon? Moderator: S. Nahum Goldberg, MD
11:15 am - 11:30 am TAEVax: Immunobiologic Treatment Effects of Embolization in a Rat HCC Model
Stephen Hunt, MD, PhD
11:30 am - 11:45 am A Pilot Study of Cryoablation Combined with Immune Checkpoint Inhibitor Therapy in Patients with PD-1 Refractory Metastatic Melanoma: Prospective Clinical Research and Correlative Laboratory Studies
Florian J. Fintelmann, MD
11:45 am - 12:00 pm Investigating the Immunobiology of Hepatocellular Carcinoma in Patients Undergoing Y90 Radioembolization
Rafael Duran, MD
12:00 pm - 12:15 pm T-Cell Clonality and Cancer Neoantigen Presentation Following Interventional Oncology (IO) Therapies: Which IO Techniques Optimally Stimulate the Immune System?
Joseph P. Erinjeri, MD, PhD
12:15 pm - 12:30 pm Break & Exhibits
12:30 pm - 1:10 pm

Lunch Symposium Presented by BTG
Y90: Moving Beyond a Palliative Approach

1:15 pm - 1:55 pm Lunch Symposium Presented by Perseon Moderator: Sohail Contractor, MD
1:15 pm - 1:35 pm New MTX 915 Mhz Antenna Graded Technology Platform
Dragan D. Nebrigic
1:35 pm - 1:55 pm Perseon Microwave System: Why, When, Where?
Damian Dupuy, MD
2:00 pm - 3:00 pm Management of Extrahepatic Biliary Tract Cancer in 2018 Moderators: William Rilling, MD and Timothy Pawlik, MD
2:00 pm - 2:12 pm Imaging of Cholangiocarcinoma: The Essentials and Beyond
Ihab Kamel, MD
2:12 pm - 2:24 pm Role of Biliary Drainage and Complex Interventions
Dong Il Gwon, MD
2:24 pm - 2:36 pm Current Surgical Strategies
Timothy Pawlik, MD
2:36 pm - 2:48 pm Systemic Therapies and Clinical Trials
Milind Javle, MD
2:48 pm - 3:00 pm Q&A
All Faculty
  Case-Based Workshop: Transarterial
Moderator: Hooman Yarmohammadi, MD
Panelists: Kyungmouk Steve Lee, MD; Bora Peynircioglu, MD; Robert Lewandowski, MD
3:00 pm - 3:15 pm Break & Exhibits
3:15 pm - 4:15 pm SIO Meets NANETS: Advances and Controversies in NET Management Moderators: Michael C. Soulen, MD and Thierry de Baere, MD
3:15 pm - 3:25 pm Recent Advances in Systemic Therapies for NETs
Jennifer Ang Chan, MD
3:25 pm - 3:35 pm Embolization Should Remain 1st-Line Therapy for Liver-Dominant NET Metastases
Thierry de Baere, MD
3:35 pm - 3:45 pm PRRT Should Become 1st-Line Therapy for Liver-Dominant NET Metastases
Lisa Bodei, MD
3:45 pm - 3:55 pm TARE Should Remain 1st-Line Embolotherapy for Liver-Dominant NET Metastases
Matthew Johnson, MD
3:55 pm - 4:05 pm TARE Causes Long-Term Toxicity and Should be Reserved for 2nd-Line
Michael C. Soulen, MD
4:05 pm - 4:15 pm The New Frontier: Intra-Arterial PRRT
Marnix Lam, MD
  Palliative Care for the Cancer Patient Moderators: Jennifer Temel, MD and Eric Hohenwalter, MD
3:15 pm - 3:25 pm Facilitating Prognostic Awareness in Patients with Advanced Cancer
Jennifer Temel, MD
3:25 pm - 3:35 pm Where Can Interventional Oncology Impact Palliation of Cancer Patients?
Camilla Zimmerman, MD
3:35 pm - 3:45 pm Interventional Supportive Care Therapies in Cancer Patients
Mihir Kamdar, MD
3:45 pm - 3:550 pm Supportive Care Therapies in Oncology
Hooman Yarmohammadi, MD
3:55 pm - 4:05 pm Musculoskeletal and Spine Tumor Interventions
Anil "Nick" Kurup, MD
4:05 pm - 4:15 pm Palliative Embolization
Eric Hohenwalter, MD
4:15 pm - 5:00 pm Break & Exhibits
5:00 pm - 6:15 pm Hepatocellular Carcinoma Tumor Board
Moderators: Luigi Solbiati, MD and Matthew Johnson, MD
Panelists: Robert Lewandowski, MD; Dong Il Gwon, MD; Robert Brown, MD; Timothy Pawlik, MD; Yasuaki Arai, MD; Pei Hong Wu, MD; Andrew Zhu, MD 
6:15 pm - 7:15 pm Founding SIO Member Special Event - By Invitation Only 
6:30 pm - 8:15 pm IO Essentials, Part II: Practice Development Moderators: Janice Newsome, MD and Kathy Krol, MD
6:30 pm - 6:45 pm Building an Academic IO Practice
William Rilling, MD
6:45 pm - 7:00 pm Building a Private IO Practice
Aneesa Majid, MD
7:00 pm - 7:15 pm Opening a Stand Alone Outpatient IO Center
David Sperling, MD
7:15 pm - 7:35 pm Demonstrating the Value of a Clinical Practice To Your Partners
Janice Newsome, MD
7:35 pm - 8:00 pm Demonstrating the Value of IO to Referring Providers
Muneeb Ahmed, MD
8:00 pm - 8:15 pm Documentation: Billing, Coding, E&M
Ray Liu, MD


Saturday, 9 June 2018
7:30 am - 8:45 am Scientific Abstract Presentations: Basic Science IO Moderators: Muneeb Ahmed, MD and David Woodrum, MD
7:30 am - 7:39 am Paper 10: Preclinical Evaluation of Locoregional Delivery of Low-Density Lipoprotein Docosahexaenoic Acid Nanoparticles Shows Promise as a Novel Treatment for Hepatocellular Carcinoma
7:39 am - 7:48 am Paper 11: Influence of Bead Size on Doxorubicin Concentration and Distribution After Transarterial Chemoembolization by Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry in a Rat Orthotopic Model of Helpatocellular Carcinoma
7:48 am - 7:57 am Paper 12: Microwave Ablation in Lung Using a Novel Thermal Accelerant Agent: Effect on Ablation Zone Volumes and Comparison of Percutaneous and Endobronchial Delivery Methods
7:57 am - 8:06 am Paper 13: Histotripsy for Non-Invasive Liver Tumor Ablation in an In Vivo Murine Hepatocellular Carcinoma Model
8:06 am - 8:15 am Paper 14: Effects of Idarubicin-Eluting Oncozene Microspheres on Pre-Clinical Tumor Microenvironment in Liver Cancer
8:15 am - 8:24 am Paper 15: Radiology Pathology Correlation of Woodchuck Hepatitis Virus-Induced Helpatic Tumors
8:24 am - 8:33 am Paper 16: Towards improving Thermal Ablation and Chemoembolization for Hepatocellular Carcinoma Through Cancer Stem Cell Inhibition
8:33 am - 8:42 am Paper 17:Micelle Paclitaxel Enhanced End-Point Survival in Percutaneous Radiofrequency Ablation of Tumors in a Mouse Model: Intravenous or Intratumoral Administration?
8:45 am - 9:00 am Break & Exhibits
9:00 am - 10:30 am Colorectal Liver Metastases: The IO Playbook Moderators: Alban Denys, MD and Daniel Brown, MD
9:00 am - 9:12 am Ablative Therapies: Are There Novel Strategies to Optimize Results for CRLM?
Constantinos Sofocleous, MD, PhD
9:12 am - 9:24 am IO Versus Resection: Defending Ablation at Multidisciplinary Tumor Boards
Alban Denys, MD
9:24 am - 9:36 am Preparing for Liver Surgery with Alphabet Soup: PVE, ALPPS, or LVD?
Boris Guiu, MD
9:36 am - 9:48 am Y90 for CRLM: Are There Indications After SIRFLOX?
Daniel Brown, MD
9:48 am - 10:00 am Chemoembolization for CRLM: Is There Sufficient Evidence to Compete with Y90?
William Rilling, MD
10:00 am - 10:30 am Tumor Board Moderator: Alban Denys, MD; Speakers: Daniel Brown, MD; Constantinos Sofocleous, MD, PhD; William Rilling, MD; Allyson Ocean, MD
  Hands-On Workshop: Imaging, Guidance, and Simulation
Moderator: Ron Winkour, MD; Speakers: Bradley Pua, MD; Nadine Abi-Jaoudeh, MD; Bradford Wood, MD; Alex Tang, MD; Reto Bale, MD
10:30 am - 11:00 am Break & Exhibits
11:00 am - 12:15 pm Video Session: "How I Do It" Moderators: Alexis Kelekis, MD and David C. Madoff, MD
11:00am - 11:12 am IRE for Complex Liver Tumors
Oliver Seror, MD
11:12 am - 12:24 pm Hardware Stabilization for Pelvic Tumors
Alexis Kelekis, MD
11:24 pm - 11:36 pm Microwave of Primary Lung Cancer
Damian Dupuy, MD
11:36 pm - 11:48 pm Transarterial Ethanol Emoblization for HCC
Alex Tang, MD
11:48 pm - 12:00 pm Complex Spine Tumor Management
Uei Pua, MD
12:00 pm - 12:12 pm Preoperative Liver Deprivation for FLR Hypertrophy
Boris Guiu, MD
  Scientific Abstract Presentations: Lung and Genitourinary Moderators: Terrance Healey, MD and Grant Schmit, MD
11:00 am - 11:10 am Paper 18: Efficacy and Radiation Exposure of an Ultralow-Dose Chest CT Protocol in CT-Guided Percutaneous Core Needle Biopsy for Small Pulmonary Lesions Using a Third-Generation Dual-Source CT Scanner
11:10 am - 11:20 am Paper 19: Clinical Application of CT-Guided RFA Combined Immediately Postoperative Biopsy of Pulmonary GGO
11:20 am - 11:30 am Paper 20: Prognostic Value of HMGB1 in Locally High-Risk Prostate Cancer Patients Receiving Primary Cryoablation Therapy
11:30 am - 11:40 am Paper 21: Radiofrequency Cryo- and Microwave Ablations For a T1a Renal Mass: A Comparative Evaluation of Therapeutic Efficacy and Oncologic Outcomes
11:40 am - 11:50 am Paper 22: The Oncologic Results of Cryoablation in Prostate Cancer Patients with Bone Metastases
11:50 am - 12:00 am Paper 23: Complication and Local Recurrence Prediction of Thermal Ablation for T1b Renal Cell Carcinoma (>4cm): Is there a Role for the R.E.N.A.L Nephrometry Scoring System?
12:15 pm - 12:45 pm Break & Exhibits
12:45 pm - 1:30 pm Lunch Symposium
12:45 pm - 1:30 pm Techniques and Advanced Imaging for Complex Endovascular and Percutaneous IO Procedures
Presented by GE, Charles Nutting, MD & Gordon McLennan, MD
1:30 pm - 1:45 pm Break
1:45 pm - 2:30 pm RCC Ablation: Understanding the How and Why
Presented by BTG, Hyun J. Bang, MD
2:30 pm - 2:45 pm Break & Exhibits
2:45 pm - 3:45 pm Breast Cancer: Update 2018 Moderator: Constantinos Sofocleous, MD, PhD
2:45 pm - 3:00 pm Current Therapy of Breast Cancer Metastatic Disease and When Local Therapy Makes Sense
Shanu Modi, MD
3:00 pm - 3:15 pm Surgery in the Management of Oligometastatic Disease from Breast Cancer
Myron Schwartz, MD
3:15 pm - 3:30 pm Update on Radiation Data and Enrolling Trials for Liver Mets
Higinia Cardenes, MD
3:30 pm - 3:45 pm IO Therapy for Liver Mets: From Ablation to IAT - Is It Useful and When?
Amy Deipolyi, MD
  Case-Based Workshop: MSK Moderator: Alexis Kelekis, MD; Speakers: Jack Jennings, MD; Frederic Deschamps, MD; Anil "Nick" Kurup, MD
3:45 pm - 4:00 pm Break & Exhibits
4:00 pm - 5:00 pm Pancreatic Cancer Moderator: Martijn Meijerink, MD, PhD
4:00 pm - 4:12 pm Role of Surgery to Treat Pancreatic Cancer
Mark Truty, MD
4:12 pm - 4:24 pm Current Medical Strategies for Unresectable Pancreatic Cancer
Allyson Ocean, MD
4:24 pm - 4:36 pm When Should Radiotherapy Be Used? The Optimal Patient and Outcomes
Ted Hong, MD
4:36 pm - 4:48 pm Percutaneous Treatment Options for Pancreatic Cancer
Martijn Meijerink, MD, PhD
4:48 pm - 5:00 pm Immunogenic Respose After IRE: Is It A Real Phenomenon?
Martijn Meijerink, MD, PhD
  Scientific Abstract Presentations: General IO Moderators: Afshin Gangi, MD and Anil "Nick" Kurup, MD
4:00 pm - 4:10 pm Paper 24: Safety and Efficacy of Combined Microwave Ablation and Cementoplasty for Painful Extra-Spinal Metastases
4:10 pm - 4:20 pm Paper 25: Clinical Experience: An Innovative Implant for the Prophylactic Treatment of Impeding Pathological Hip Fracture in 37 Patients
4:20 pm - 4:30 pm Paper 26: Evaluation of Long-Term Functionality: Percutaneous Trans-Femoral Implantation of Side-Hole Port-Catheter System with Coils-Fixed-Catheter-Tip Methods for Hepatic Arterial Infusion Chemotherapy
4:30 pm - 4:40 pm Paper 27: Ultrasound-Guided Percutaneous Microwave Ablation of Papillary Thyroid Microcarcinoma: Mid-Term Efficacy Observation
4:40 pm - 4:50 pm Paper 28: Current State of Palliative Care Training in Interventional Radiology Fellowship: A Survey of Recent IR Trainees
4:50 pm - 5:00 pm Paper 29: Chest Port-Related Venous Thrombosis in Patients with Solid Cancer: Incidence and Risk Factors
5:00 pm - 5:15 pm Break & Exhibits
5:15 pm - 6:30 pm Hot Topic Debates Moderators: Damian Dupuy, MD and Matthew Callstrom, MD, PhD
5:15 pm - 5:35 pm Lung Ablation versus Surgery for Lung Metastases
Alice Gillams, MD vs. Ashok Muniappan, MD
5:35 pm - 5:50 pm Percutaneous Ablation vs SBRT for Liver Tumors
Jim Smith Apisarnthanarax, MD vs. David Breen, MD
5:50 pm - 6:10 pm Pancreatic IRE for Marginally Resectable
Mark Truty, MD vs. Martijn Meijerink, MD, PhD
6:10 pm - 6:30 pm Portal Vein Embolization vs Radiation Lobectomy for Liver Remnant Hypertrophy
David C. Madoff, MD vs. Ryan Hickey, MD
6:30 pm - 7:30 pm Poster Award Reception: Author Meet & Greet
7:30 pm - 10:00 pm WCIO Social Event at Harpoon Brewery – Registration Required


Sunday, 10 June 2018
9:00 am - 10:30 am Morbidity and Mortality Moderators: David Lu, MD and Kevin Kim, MD
9:00 am - 9:15 am Liver Cancer: Ablation
David Lu, MD
9:15 am - 9:30 am Liver Cancer: Transcatheter
Kevin Kim, MD
9:30 am - 9:45 am Kidney Cancer
Timothy Ziemlewicz, MD
9:45 am - 10:00 am Lung Cancer
Fereidoun Abtin, MD
10:00 am - 10:15 am MSK and Spine Cancer
Afshin Gangi, MD
10:15 am - 10:30 am Soft Tissue and Nodal Cancer
Peter Littrup
10:30 am - 10:45 am Break
10:45 am - 12:00 am Extreme IO Moderators:Frederic Deschamps, MD and Luigi Solbiati, MD
10:45 am - 10:55 am MSK Spine
Jack Jennings, MD
10:55 am - 11:05 am MSK Non-Spine
Frederic Deschamps, MD
11:05 am - 11:15 am Liver Transcatheter
Luigi Solbiati, MD
11:15 am - 11:25 am Liver Ablation
Luigi Solbiati, MD
11:25 am - 11:35 am Primary Lung
Alice Gillams, MD
11:35 am - 11:45 am Kidney
Debra Gervais, MD
11:45 am - 11:55 am Lung Metastases
Matthew Callstrom, MD, PhD
12:00 pm - 12:30 pm Closing